HY
Healthy Extracts Inc.
HYEX · OTC
$1.05 +0.00% (+$0.00)
1M -13.93%
Market Cap $15.5M
P/E Ratio -
Div. Yield -
ROE 3.72%
Bulios Fair Price
$0.71
32.4% downside
Current Price
$1.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HYEX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
60 /100
Fair P/B 0.69x
P/FCF 30.94x
P/S 2.46x
Growth
100 /100
Growing Book val. growth 133.88%
Rev. growth 26.08%
FCF growth N/A
Profitability
37 /100
Moderate Net margin 13.98%
Op. margin 17.60%
FCF margin 7.95%
Quality
2 /100
Poor ROE 3.72%
ROA 2.70%
Asset turnover 0.19x
Debt
42 /100
Moderate Current ratio 0.20x
Int. coverage -2.92x
Debt/Equity 0.40x
Stability
33 /100
Unstable Rev. volatility 17.32%
EPS volatility 125.07%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HYEX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Donald Swanson
Employees
22
Headquarters
Henderson
Upcoming events
17 NOV
Earnings
Upcoming earnings report